Cambridge Investment Research Advisors, Inc. Amyris, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	BUY	$0.58 - $1.3 $145 - $325	250 Added 1.68%	15,167 $16,000
Q1 2023 May 11, 2023	BUY	$1.09 - $1.82 $2,066 - $3,450	1,896 Added 14.56%	14,917 $20,000
Q3 2022 Oct 17, 2022	SELL	$1.7 - $4.05 $16,998 - $40,495	-9,999 Reduced 43.44%	13,021 $38,000
Q2 2022 Jul 13, 2022	BUY	$1.6 - $5.07 $1,120 - $3,549	700 Added 3.14%	23,020 $42,000
Q1 2022 May 12, 2022	BUY	$3.92 - $5.86 $3,920 - $5,860	1,000 Added 4.69%	22,320 $97,000
Q4 2021 Feb 03, 2022	BUY	$5.0 - $14.85 $30,720 - $91,238	6,144 Added 40.48%	21,320 $115,000
Q3 2021 Nov 02, 2021	BUY	$12.13 - $16.99 $184,084 - $257,840	15,176 New	15,176 $208,000

Others Institutions Holding AMRS

# of Institutions

Shares Held

230K

Call Options Held

Put Options Held

View Full List

About AMYRIS, INC.

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

More about AMRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account